PALO ALTO, Calif., Nov. 5, 2010 /PRNewswire/ — Varian Medical
Systems (NYSE:
VAR) is scheduled to present at Lazard Capital Markets
Healthcare Conference at 9:30 a.m. ET on Wednesday, November 17th
at the St. Regis Hotel in New York City.
Participating executives will include Elisha Finney, senior vice
president and CFO, and Spencer Sias, vice president of investor
relations and corporate communications. The presentation will focus
on the company’s growth opportunities in radiation oncology, X-ray
imaging, proton therapy and security and inspection.
Varian Medical Systems, Inc., of Palo Alto, California, is the
world’s leading manufacturer of medical devices and software for
treating cancer and other medical conditions with radiotherapy,
radiosurgery, proton therapy, and brachytherapy. The company
supplies informatics software for managing comprehensive cancer
clinics, radiotherapy centers and medical oncology practices.
Varian is a premier supplier of tubes and digital detectors for
X-ray imaging in medical, scientific, and industrial applications
and also supplies X-ray imaging products for cargo screening and
industrial inspection. Varian Medical Systems employs approximately
5,100 people who are located at manufacturing sites in North
America, China and Europe and in its 79 sales and support offices
around the world. For more information, visit http://www.varian.com.FOR
INFORMATION CONTACT:Spencer Sias, (650) 424-5782Vice President,
Corporate Communicationsand Investor Relations
spencer.sias@varian.com
‘/>”/>
